<VariationArchive RecordType="classified" VariationID="1805740" VariationName="NM_001127222.2(CACNA1A):c.5021del (p.Gly1674fs)" VariationType="Deletion" Accession="VCV001805740" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1862751" VariationID="1805740">
      <GeneList>
        <Gene Symbol="CACNA1A" FullName="calcium voltage-gated channel subunit alpha1 A" GeneID="773" HGNC_ID="HGNC:1388" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13206442" stop="13506479" display_start="13206442" display_stop="13506479" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13317255" stop="13617273" display_start="13317255" display_stop="13617273" Strand="-" />
          </Location>
          <OMIM>601011</OMIM>
          <Haploinsufficiency last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001127222.2(CACNA1A):c.5021del (p.Gly1674fs)</Name>
      <CanonicalSPDI>NC_000019.10:13235659:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13235660" stop="13235660" display_start="13235660" display_stop="13235660" variantLength="1" positionVCF="13235659" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13346474" stop="13346474" display_start="13346474" display_stop="13346474" variantLength="1" positionVCF="13346473" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>G1674fs</ProteinChange>
      <ProteinChange>G1675fs</ProteinChange>
      <ProteinChange>G1677fs</ProteinChange>
      <ProteinChange>G1680fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_7" sequenceAccession="LRG_7">
            <Expression>LRG_7:g.275801del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_7t1" sequenceAccession="LRG_7t1">
            <Expression>LRG_7t1:c.5022del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_7p1" sequenceAccession="LRG_7p1" change="p.Gly1675Valfs">
            <Expression>LRG_7p1:p.Gly1675Valfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127221.1" sequenceAccession="NM_001127221" sequenceVersion="1" change="c.5024delG">
            <Expression>NM_001127221.1:c.5024delG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.13235662del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.13235662del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.13346476del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.13346476del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011569.1" sequenceAccession="NG_011569" sequenceVersion="1" change="g.275801del">
            <Expression>NG_011569.1:g.275801del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000068.4" sequenceAccession="NM_000068" sequenceVersion="4" change="c.5039del">
            <Expression>NM_000068.4:c.5039del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000059.3" sequenceAccession="NP_000059" sequenceVersion="3" change="p.Gly1680fs">
            <Expression>NP_000059.3:p.Gly1680fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127221.2" sequenceAccession="NM_001127221" sequenceVersion="2" change="c.5024del">
            <Expression>NM_001127221.2:c.5024del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120693.1" sequenceAccession="NP_001120693" sequenceVersion="1" change="p.Gly1675fs">
            <Expression>NP_001120693.1:p.Gly1675fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127222.2" sequenceAccession="NM_001127222" sequenceVersion="2" change="c.5021del" MANESelect="true">
            <Expression>NM_001127222.2:c.5021del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120694.1" sequenceAccession="NP_001120694" sequenceVersion="1" change="p.Gly1674fs">
            <Expression>NP_001120694.1:p.Gly1674fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001174080.2" sequenceAccession="NM_001174080" sequenceVersion="2" change="c.5030del">
            <Expression>NM_001174080.2:c.5030del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001167551.1" sequenceAccession="NP_001167551" sequenceVersion="1" change="p.Gly1677fs">
            <Expression>NP_001167551.1:p.Gly1677fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_023035.3" sequenceAccession="NM_023035" sequenceVersion="3" change="c.5039del">
            <Expression>NM_023035.3:c.5039del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_075461.2" sequenceAccession="NP_075461" sequenceVersion="2" change="p.Gly1680fs">
            <Expression>NP_075461.2:p.Gly1680fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001127222.2(CACNA1A):c.5021del (p.Gly1674fs) AND Developmental and epileptic encephalopathy, 42" Accession="RCV002472158" Version="1">
        <ClassifiedConditionList TraitSetID="32571">
          <ClassifiedCondition DB="MedGen" ID="C4310716">Developmental and epileptic encephalopathy, 42</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-05-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-05-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18606230</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20129625</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28566750</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31468518</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="32571" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36150" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 42</ElementValue>
                <XRef ID="MONDO:0014917" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 42</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE42</ElementValue>
                <XRef Type="MIM" ID="617106" DB="OMIM" />
              </Symbol>
              <XRef ID="C4310716" DB="MedGen" />
              <XRef ID="MONDO:0014917" DB="MONDO" />
              <XRef Type="MIM" ID="617106" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5414354" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_001127221_1_CACNA1A_c_5024delG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002768617" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18606230</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20129625</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28566750</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31468518</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as 5-Pathogenic. Following criteria are met: 0103 - Both loss- and gain-of-function are known mechanisms of disease for this gene (PMID: 31468518). (N) 0107 - Loss of function variants in this gene is known to be associated with autosomal dominant episodic ataxia, type 2 (OMIM). (N) 0112 - Variants in this gene are known to have reduced penetrance (OMIM; PMID: 20129625). (N) 0205 - Variant is predicted to result in a truncated protein with less than 1/3 of the protein affected (exon 32 of 47). (P) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0600 - Variant is located in an ion transport domain (NCBI conserved domain). (P) 0702 - Comparable variants have very strong previous evidence for pathogenicity. Multiple downstream pathogenic truncating variants have been reported (ClinVar; PMID: 28566750, 20129625, 18606230). (P) 0807 - Variant has not previously been reported in a clinical context. (N) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_2550</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001127221.1:c.5024delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0014917" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5414354" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0014917" MappingRef="MONDO">
        <MedGen CUI="C4310716" Name="Developmental and epileptic encephalopathy, 42" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

